» Articles » PMID: 34867300

Diffusion Tensor Imaging Along the Perivascular Space Index in Different Stages of Parkinson's Disease

Overview
Specialty Geriatrics
Date 2021 Dec 6
PMID 34867300
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to evaluate the glymphatic system activity in patients with Parkinson's disease (PD) using the diffusion tensor image analysis along the perivascular space (DTI-ALPS) methods. In total, 71 patients with idiopathic PD and 36 age- and sex-matched normal controls (NCs) were involved. Patients with PD were divided into early ( = 35) and late ( = 36) subgroups, based on Hoehn and Yahr (HY) stages. We calculated the diffusivity along the perivascular spaces (ALPS), as well as projection fibers and association fibers separately, to acquire the ALPS index. Enlarged perivascular spaces (EPVS) and periventricular white matter hyperintensities were also rated. Differences in ALPS index between the PD group and NCs and between two PD subgroups and NCs were compared. In addition, a multivariate logistic regression analysis was conducted to investigate the association between ALPS index and clinical variables. Patients with PD revealed lower ALPS index than NCs ( = 0.010). The late PD group exhibited significantly lower ALPS index than NCs ( = 0.006). However, there were no marked differences noticed in ALPS index between NCs and early PD group and between the two PD subgroups. In the early PD group, there was a significantly positive correlation between ALPS index and Mini-Mental State Examination (MMSE) score (β = 0.021, = 0.029) and a negative correlation between ALPS index and EPVS score (β = -0.050, = 0.034), after controlling for multiple variables. In the late PD group, ALPS index was inversely associated with age (β = -0.012, = 0.004). Impairment of the glymphatic system is involved in PD. DTI-ALPS index could be a promising biomarker of glymphatic system in PD.

Citing Articles

Glymphatic system dysfunction as a biomarker of disease progression in Parkinson's disease: neuroimaging evidence from longitudinal cohort studies.

Ren J, Xie D, Wang L, Wu Z, Lin S, Jin Q J Neurol. 2025; 272(3):196.

PMID: 39932513 DOI: 10.1007/s00415-025-12944-1.


Perivascular and parenchymal brain fluid diffusivity in patients with a recent small subcortical infarct.

Rudilosso S, Munoz-Moreno E, Laredo C, Calvet A, Rodriguez-Vazquez A, Girona A Neuroradiology. 2025; .

PMID: 39853343 DOI: 10.1007/s00234-025-03546-9.


Associations of ventriculomegaly and white matter hyperintensities with glymphatic dysfunction in idiopathic normal pressure hydrocephalus.

Wu Q, Chen J, Yang X, Zhang X, He W, Xia J Eur Radiol. 2025; .

PMID: 39836203 DOI: 10.1007/s00330-024-11320-3.


Diffusion tensor imaging along the perivascular space: the bias from crossing fibres.

Georgiopoulos C, Werlin A, Lasic S, Hall S, van Westen D, Spotorno N Brain Commun. 2024; 6(6):fcae421.

PMID: 39713238 PMC: 11660947. DOI: 10.1093/braincomms/fcae421.


Evaluating the robustness of DTI-ALPS in clinical context: a meta-analytic parallel on Alzheimer's and Parkinson's diseases.

Costa T, Manuello J, Premi E, Mattioli I, Lasagna L, Lahoz C Sci Rep. 2024; 14(1):26381.

PMID: 39487289 PMC: 11530450. DOI: 10.1038/s41598-024-78132-9.


References
1.
Ding X, Wang X, Xia D, Liu H, Tian H, Fu Y . Impaired meningeal lymphatic drainage in patients with idiopathic Parkinson's disease. Nat Med. 2021; 27(3):411-418. DOI: 10.1038/s41591-020-01198-1. View

2.
Wardlaw J, Benveniste H, Nedergaard M, Zlokovic B, Mestre H, Lee H . Perivascular spaces in the brain: anatomy, physiology and pathology. Nat Rev Neurol. 2020; 16(3):137-153. DOI: 10.1038/s41582-020-0312-z. View

3.
Fang Y, Gu L, Tian J, Dai S, Chen Y, Zheng R . MRI-visible perivascular spaces are associated with cerebrospinal fluid biomarkers in Parkinson's disease. Aging (Albany NY). 2020; 12(24):25805-25818. PMC: 7803484. DOI: 10.18632/aging.104200. View

4.
Fazekas F, Chawluk J, Alavi A, Hurtig H, Zimmerman R . MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987; 149(2):351-6. DOI: 10.2214/ajr.149.2.351. View

5.
Iliff J, Wang M, Liao Y, Plogg B, Peng W, Gundersen G . A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med. 2012; 4(147):147ra111. PMC: 3551275. DOI: 10.1126/scitranslmed.3003748. View